SITE-DIRECTED MUTAGENESIS OF SARS-COV-2 ITB SPIKE DNA FOR DEVELOPMENT OF COVID-19 MRNA VACCINE CANDIDATES
COVID-19 mRNA vaccine is one of the types of COVID-19 vaccines still being developed. Compared to other COVID-19 vaccine platforms, mRNA vaccines have safety, efficacy, rapid development, and low-cost manufacturing advantages. COVID-19 mRNA vaccine contains the genetic material mRNA to encode SAR...
Saved in:
Main Author: | Lilis Fitriani, Annisa |
---|---|
Format: | Final Project |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/78729 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
IMMUNOGENICITY OF MULTIEPITOPE VACCINE CANDIDATE SPIKE AND NSP3 PROTEIN FUSION SARS-COV-2 IN BALB/C MICE
by: Meliana Shani, Annisa -
Mice immunized with the vaccine candidate hexapro spike produce neutralizing antibodies against sars-cov-2
by: Chotiwat Seephetdee, et al.
Published: (2022) -
The STING Ligand and Delivery System Synergistically Enhance the Immunogenicity of an Intranasal Spike SARS-CoV-2 Vaccine Candidate
by: Tuksin Jearanaiwitayakul, et al.
Published: (2022) -
The STING Ligand and Delivery System Synergistically Enhance the Immunogenicity of an Intranasal Spike SARS-CoV-2 Vaccine Candidate
by: Jearanaiwitayakul T.
Published: (2023) -
Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice
by: Prompetchara E.
Published: (2023)